Read + Share
Amedeo Smart
Independent Medical Education
Fabrizio C, Valzano F, Giuliano S, Morelli E, et al. Optimizing target inactivation to treat multidrug-resistant Escherichia coli with NDM and PBP3 mutations: "going the extra mile". Antimicrob Agents Chemother 2026;70:e0088725.PMID: 41718487
Email
LinkedIn
Privacy Policy